Semantic Scholar uses AI to extract papers important to this topic.
ObjectiveTo compare the effectiveness and safety of low-dose unfractionated heparin and a low-molecular-weight heparin as… Expand BACKGROUND
Cardiopulmonary bypass (CPB) induces platelet activation with release of platelet factor 4 (PF4), and patients are… Expand Heparin‐induced thrombocytopenia is a rare but severe complication of heparin therapy that can result in severe venous or… Expand OBJECTIVE
To determine the relative efficacy and safety of low molecular weight (LMW) heparin (Enoxaparin) compared with standard… Expand A double blind randomized trial comparing subcutaneous enoxaparin (40 mg once daily) with standard unfractionated calcium heparin… Expand In a prospective, randomized multicentre trial the efficacy and safety of the low molecular weight heparin (LMWH) fraction… Expand STUDY OBJECTIVE
To determine the efficacy and safety of adjusted subcutaneous calcium heparin compared with continuous… Expand Venous thrombo-embolism is a major and often unrecognized cause of morbidity and mortality in patients after acute strokes. Three… Expand The efficacy and safety of a low‐molecular‐weight (LMW) heparin fraction in preventing postoperative venous thrombo‐embolism, was… Expand Randomized clinical trials in 300 patients undergoing major abdominal surgery or hip replacement arthroplasty were performed to… Expand